nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP1A2—Dacarbazine—muscle cancer	0.162	0.174	CbGbCtD
Praziquantel—CYP3A7—Vincristine—muscle cancer	0.155	0.166	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.155	0.166	CbGbCtD
Praziquantel—CYP3A5—Vincristine—muscle cancer	0.116	0.124	CbGbCtD
Praziquantel—CYP3A5—Etoposide—muscle cancer	0.106	0.114	CbGbCtD
Praziquantel—CYP1A2—Etoposide—muscle cancer	0.0792	0.0849	CbGbCtD
Praziquantel—CYP3A4—Vincristine—muscle cancer	0.0453	0.0485	CbGbCtD
Praziquantel—CYP2D6—Doxorubicin—muscle cancer	0.0445	0.0477	CbGbCtD
Praziquantel—CYP3A4—Etoposide—muscle cancer	0.0415	0.0445	CbGbCtD
Praziquantel—CYP3A4—Doxorubicin—muscle cancer	0.0283	0.0303	CbGbCtD
Praziquantel—Diarrhoea haemorrhagic—Doxorubicin—muscle cancer	0.00332	0.0493	CcSEcCtD
Praziquantel—Bone disorder—Methotrexate—muscle cancer	0.00107	0.0159	CcSEcCtD
Praziquantel—Cardiac disorder—Vincristine—muscle cancer	0.000932	0.0138	CcSEcCtD
Praziquantel—Bone disorder—Doxorubicin—muscle cancer	0.00093	0.0138	CcSEcCtD
Praziquantel—Ill-defined disorder—Dactinomycin—muscle cancer	0.000907	0.0135	CcSEcCtD
Praziquantel—Malaise—Dactinomycin—muscle cancer	0.000882	0.0131	CcSEcCtD
Praziquantel—Atrioventricular block—Doxorubicin—muscle cancer	0.000866	0.0128	CcSEcCtD
Praziquantel—Myalgia—Dactinomycin—muscle cancer	0.000833	0.0123	CcSEcCtD
Praziquantel—Discomfort—Dactinomycin—muscle cancer	0.000823	0.0122	CcSEcCtD
Praziquantel—Vertigo—Vincristine—muscle cancer	0.000785	0.0116	CcSEcCtD
Praziquantel—Anorexia—Dactinomycin—muscle cancer	0.000761	0.0113	CcSEcCtD
Praziquantel—Convulsion—Vincristine—muscle cancer	0.000757	0.0112	CcSEcCtD
Praziquantel—Cardiac disorder—Etoposide—muscle cancer	0.000755	0.0112	CcSEcCtD
Praziquantel—Myalgia—Vincristine—muscle cancer	0.000744	0.011	CcSEcCtD
Praziquantel—Immune system disorder—Etoposide—muscle cancer	0.000734	0.0109	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000727	0.0108	CcSEcCtD
Praziquantel—Nervous system disorder—Vincristine—muscle cancer	0.000699	0.0104	CcSEcCtD
Praziquantel—Decreased appetite—Dactinomycin—muscle cancer	0.000694	0.0103	CcSEcCtD
Praziquantel—Fatigue—Dactinomycin—muscle cancer	0.000688	0.0102	CcSEcCtD
Praziquantel—Anorexia—Vincristine—muscle cancer	0.00068	0.0101	CcSEcCtD
Praziquantel—Feeling abnormal—Dactinomycin—muscle cancer	0.000658	0.00976	CcSEcCtD
Praziquantel—Ill-defined disorder—Etoposide—muscle cancer	0.000657	0.00974	CcSEcCtD
Praziquantel—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000653	0.00968	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00065	0.00964	CcSEcCtD
Praziquantel—Malaise—Etoposide—muscle cancer	0.000638	0.00947	CcSEcCtD
Praziquantel—Vertigo—Etoposide—muscle cancer	0.000636	0.00943	CcSEcCtD
Praziquantel—Body temperature increased—Dactinomycin—muscle cancer	0.000631	0.00936	CcSEcCtD
Praziquantel—Abdominal pain—Dactinomycin—muscle cancer	0.000631	0.00936	CcSEcCtD
Praziquantel—Decreased appetite—Vincristine—muscle cancer	0.00062	0.00919	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Vincristine—muscle cancer	0.000616	0.00913	CcSEcCtD
Praziquantel—Fatigue—Vincristine—muscle cancer	0.000615	0.00912	CcSEcCtD
Praziquantel—Convulsion—Etoposide—muscle cancer	0.000613	0.0091	CcSEcCtD
Praziquantel—Eosinophilia—Methotrexate—muscle cancer	0.000602	0.00894	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000598	0.00888	CcSEcCtD
Praziquantel—Discomfort—Etoposide—muscle cancer	0.000595	0.00883	CcSEcCtD
Praziquantel—Hypersensitivity—Dactinomycin—muscle cancer	0.000588	0.00872	CcSEcCtD
Praziquantel—Abdominal discomfort—Methotrexate—muscle cancer	0.000583	0.00865	CcSEcCtD
Praziquantel—Gastrointestinal pain—Vincristine—muscle cancer	0.000583	0.00865	CcSEcCtD
Praziquantel—Asthenia—Dactinomycin—muscle cancer	0.000573	0.00849	CcSEcCtD
Praziquantel—Body temperature increased—Vincristine—muscle cancer	0.000564	0.00836	CcSEcCtD
Praziquantel—Abdominal pain—Vincristine—muscle cancer	0.000564	0.00836	CcSEcCtD
Praziquantel—Skin disorder—Etoposide—muscle cancer	0.000561	0.00832	CcSEcCtD
Praziquantel—Anorexia—Etoposide—muscle cancer	0.000551	0.00817	CcSEcCtD
Praziquantel—Diarrhoea—Dactinomycin—muscle cancer	0.000546	0.0081	CcSEcCtD
Praziquantel—Drowsiness—Methotrexate—muscle cancer	0.000543	0.00805	CcSEcCtD
Praziquantel—Hypersensitivity—Vincristine—muscle cancer	0.000525	0.00779	CcSEcCtD
Praziquantel—Eosinophilia—Doxorubicin—muscle cancer	0.000522	0.00774	CcSEcCtD
Praziquantel—Somnolence—Etoposide—muscle cancer	0.000514	0.00762	CcSEcCtD
Praziquantel—Asthenia—Vincristine—muscle cancer	0.000512	0.00759	CcSEcCtD
Praziquantel—Vomiting—Dactinomycin—muscle cancer	0.000508	0.00753	CcSEcCtD
Praziquantel—Rash—Dactinomycin—muscle cancer	0.000503	0.00746	CcSEcCtD
Praziquantel—Decreased appetite—Etoposide—muscle cancer	0.000502	0.00745	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Etoposide—muscle cancer	0.000499	0.0074	CcSEcCtD
Praziquantel—Fatigue—Etoposide—muscle cancer	0.000498	0.00739	CcSEcCtD
Praziquantel—Diarrhoea—Vincristine—muscle cancer	0.000488	0.00724	CcSEcCtD
Praziquantel—Feeling abnormal—Etoposide—muscle cancer	0.000476	0.00706	CcSEcCtD
Praziquantel—Nausea—Dactinomycin—muscle cancer	0.000474	0.00703	CcSEcCtD
Praziquantel—Gastrointestinal pain—Etoposide—muscle cancer	0.000472	0.00701	CcSEcCtD
Praziquantel—Dizziness—Vincristine—muscle cancer	0.000472	0.00699	CcSEcCtD
Praziquantel—Drowsiness—Doxorubicin—muscle cancer	0.00047	0.00697	CcSEcCtD
Praziquantel—Urticaria—Etoposide—muscle cancer	0.000459	0.00681	CcSEcCtD
Praziquantel—Abdominal pain—Etoposide—muscle cancer	0.000457	0.00677	CcSEcCtD
Praziquantel—Body temperature increased—Etoposide—muscle cancer	0.000457	0.00677	CcSEcCtD
Praziquantel—Vomiting—Vincristine—muscle cancer	0.000453	0.00673	CcSEcCtD
Praziquantel—Cardiac disorder—Methotrexate—muscle cancer	0.000452	0.0067	CcSEcCtD
Praziquantel—Rash—Vincristine—muscle cancer	0.00045	0.00667	CcSEcCtD
Praziquantel—Dermatitis—Vincristine—muscle cancer	0.000449	0.00666	CcSEcCtD
Praziquantel—Headache—Vincristine—muscle cancer	0.000447	0.00663	CcSEcCtD
Praziquantel—Immune system disorder—Methotrexate—muscle cancer	0.00044	0.00653	CcSEcCtD
Praziquantel—Bradycardia—Doxorubicin—muscle cancer	0.000429	0.00637	CcSEcCtD
Praziquantel—Hypersensitivity—Etoposide—muscle cancer	0.000426	0.00631	CcSEcCtD
Praziquantel—Nausea—Vincristine—muscle cancer	0.000424	0.00628	CcSEcCtD
Praziquantel—Asthenia—Etoposide—muscle cancer	0.000414	0.00615	CcSEcCtD
Praziquantel—Pruritus—Etoposide—muscle cancer	0.000409	0.00606	CcSEcCtD
Praziquantel—Diarrhoea—Etoposide—muscle cancer	0.000395	0.00586	CcSEcCtD
Praziquantel—Ill-defined disorder—Methotrexate—muscle cancer	0.000393	0.00583	CcSEcCtD
Praziquantel—Cardiac disorder—Doxorubicin—muscle cancer	0.000391	0.00581	CcSEcCtD
Praziquantel—Malaise—Methotrexate—muscle cancer	0.000382	0.00567	CcSEcCtD
Praziquantel—Dizziness—Etoposide—muscle cancer	0.000382	0.00567	CcSEcCtD
Praziquantel—Immune system disorder—Doxorubicin—muscle cancer	0.000381	0.00565	CcSEcCtD
Praziquantel—Vertigo—Methotrexate—muscle cancer	0.000381	0.00565	CcSEcCtD
Praziquantel—Arrhythmia—Doxorubicin—muscle cancer	0.000377	0.00559	CcSEcCtD
Praziquantel—Convulsion—Methotrexate—muscle cancer	0.000367	0.00545	CcSEcCtD
Praziquantel—Vomiting—Etoposide—muscle cancer	0.000367	0.00545	CcSEcCtD
Praziquantel—Rash—Etoposide—muscle cancer	0.000364	0.0054	CcSEcCtD
Praziquantel—Dermatitis—Etoposide—muscle cancer	0.000364	0.0054	CcSEcCtD
Praziquantel—Headache—Etoposide—muscle cancer	0.000362	0.00537	CcSEcCtD
Praziquantel—Myalgia—Methotrexate—muscle cancer	0.000361	0.00535	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000358	0.00532	CcSEcCtD
Praziquantel—Discomfort—Methotrexate—muscle cancer	0.000357	0.00529	CcSEcCtD
Praziquantel—Nausea—Etoposide—muscle cancer	0.000343	0.00509	CcSEcCtD
Praziquantel—Ill-defined disorder—Doxorubicin—muscle cancer	0.000341	0.00505	CcSEcCtD
Praziquantel—Nervous system disorder—Methotrexate—muscle cancer	0.000339	0.00503	CcSEcCtD
Praziquantel—Skin disorder—Methotrexate—muscle cancer	0.000336	0.00499	CcSEcCtD
Praziquantel—Malaise—Doxorubicin—muscle cancer	0.000331	0.00491	CcSEcCtD
Praziquantel—Vertigo—Doxorubicin—muscle cancer	0.00033	0.00489	CcSEcCtD
Praziquantel—Anorexia—Methotrexate—muscle cancer	0.00033	0.00489	CcSEcCtD
Praziquantel—Convulsion—Doxorubicin—muscle cancer	0.000318	0.00472	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000315	0.00468	CcSEcCtD
Praziquantel—Myalgia—Doxorubicin—muscle cancer	0.000313	0.00464	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00031	0.0046	CcSEcCtD
Praziquantel—Discomfort—Doxorubicin—muscle cancer	0.000309	0.00458	CcSEcCtD
Praziquantel—Somnolence—Methotrexate—muscle cancer	0.000308	0.00456	CcSEcCtD
Praziquantel—Decreased appetite—Methotrexate—muscle cancer	0.000301	0.00446	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000299	0.00443	CcSEcCtD
Praziquantel—Fatigue—Methotrexate—muscle cancer	0.000298	0.00442	CcSEcCtD
Praziquantel—Nervous system disorder—Doxorubicin—muscle cancer	0.000294	0.00436	CcSEcCtD
Praziquantel—Skin disorder—Doxorubicin—muscle cancer	0.000291	0.00432	CcSEcCtD
Praziquantel—Anorexia—Doxorubicin—muscle cancer	0.000286	0.00424	CcSEcCtD
Praziquantel—Feeling abnormal—Methotrexate—muscle cancer	0.000285	0.00423	CcSEcCtD
Praziquantel—Gastrointestinal pain—Methotrexate—muscle cancer	0.000283	0.0042	CcSEcCtD
Praziquantel—Urticaria—Methotrexate—muscle cancer	0.000275	0.00408	CcSEcCtD
Praziquantel—Abdominal pain—Methotrexate—muscle cancer	0.000274	0.00406	CcSEcCtD
Praziquantel—Body temperature increased—Methotrexate—muscle cancer	0.000274	0.00406	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000273	0.00405	CcSEcCtD
Praziquantel—Somnolence—Doxorubicin—muscle cancer	0.000266	0.00395	CcSEcCtD
Praziquantel—Decreased appetite—Doxorubicin—muscle cancer	0.00026	0.00386	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000259	0.00384	CcSEcCtD
Praziquantel—Fatigue—Doxorubicin—muscle cancer	0.000258	0.00383	CcSEcCtD
Praziquantel—Hypersensitivity—Methotrexate—muscle cancer	0.000255	0.00378	CcSEcCtD
Praziquantel—Asthenia—Methotrexate—muscle cancer	0.000248	0.00368	CcSEcCtD
Praziquantel—Feeling abnormal—Doxorubicin—muscle cancer	0.000247	0.00366	CcSEcCtD
Praziquantel—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000245	0.00363	CcSEcCtD
Praziquantel—Pruritus—Methotrexate—muscle cancer	0.000245	0.00363	CcSEcCtD
Praziquantel—Urticaria—Doxorubicin—muscle cancer	0.000238	0.00353	CcSEcCtD
Praziquantel—Abdominal pain—Doxorubicin—muscle cancer	0.000237	0.00351	CcSEcCtD
Praziquantel—Body temperature increased—Doxorubicin—muscle cancer	0.000237	0.00351	CcSEcCtD
Praziquantel—Diarrhoea—Methotrexate—muscle cancer	0.000237	0.00351	CcSEcCtD
Praziquantel—Dizziness—Methotrexate—muscle cancer	0.000229	0.00339	CcSEcCtD
Praziquantel—Hypersensitivity—Doxorubicin—muscle cancer	0.000221	0.00327	CcSEcCtD
Praziquantel—Vomiting—Methotrexate—muscle cancer	0.00022	0.00326	CcSEcCtD
Praziquantel—Rash—Methotrexate—muscle cancer	0.000218	0.00324	CcSEcCtD
Praziquantel—Dermatitis—Methotrexate—muscle cancer	0.000218	0.00323	CcSEcCtD
Praziquantel—Headache—Methotrexate—muscle cancer	0.000217	0.00322	CcSEcCtD
Praziquantel—Asthenia—Doxorubicin—muscle cancer	0.000215	0.00319	CcSEcCtD
Praziquantel—Pruritus—Doxorubicin—muscle cancer	0.000212	0.00314	CcSEcCtD
Praziquantel—Nausea—Methotrexate—muscle cancer	0.000206	0.00305	CcSEcCtD
Praziquantel—Diarrhoea—Doxorubicin—muscle cancer	0.000205	0.00304	CcSEcCtD
Praziquantel—Dizziness—Doxorubicin—muscle cancer	0.000198	0.00294	CcSEcCtD
Praziquantel—Vomiting—Doxorubicin—muscle cancer	0.000191	0.00283	CcSEcCtD
Praziquantel—Rash—Doxorubicin—muscle cancer	0.000189	0.0028	CcSEcCtD
Praziquantel—Dermatitis—Doxorubicin—muscle cancer	0.000189	0.0028	CcSEcCtD
Praziquantel—Headache—Doxorubicin—muscle cancer	0.000188	0.00278	CcSEcCtD
Praziquantel—Nausea—Doxorubicin—muscle cancer	0.000178	0.00264	CcSEcCtD
